Anzeige
Mehr »
Samstag, 14.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
97 Leser
Artikel bewerten:
(0)

Research and Markets - Global RTD Infant Milk Market 2017-2021 with Abbott, Danone, Mead Johnson Nutrition & Nestle Dominating

DUBLIN, Mar 16, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Global RTD Infant Milk Market 2017-2021" report to their offering.

Research and Markets Logo

The global RTD infant milk market to grow at a CAGR of 3.74% during the period 2017-2021.

Global RTD Infant Milk Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. To calculate the market size, the report considers the revenue generated from the retail sales of RTD infant milk products in the global market.

According to the report, one driver in market is wide product portfolio. A wide range of baby foods and infant formulas propel the market growth globally owing to the increasing demand from the parents seeking different variants. The various requirements include different formulas, different sizes, genders, age groups, variants of flavors, and product packaging. Manufacturers such as Abbott, Mead Johnson Nutrition, and Nestlé offer infant formula products with different variants under their flagship brands Similac (Abbott), Enfamil and Enfagrow (Mead Johnson Nutrition), and Gerber (Nestlé).

Despite altering the milk formula with whey, milk formula differs from breast milk because of its different amino acid and protein composition. However, RTD infant milk formula contains the necessary nutrients for babies to grow. Further, RTD infant milk formula also contains the necessary added nutrients and vitamins such as iron, which aids in preventing anemia. Some RTD infant milk formulas also contain probiotic Bifidobacterium lactis, which significantly reduces colic, lowers the risk of food allergies, and helps in reducing diarrhea. Commercial prepared milk formula brands thus meet the nutritional requirement and safety standards.

Further, the report states that one challenge in market is gap between nutritional and immune strengthening benefits from breast milk. Being known as breastfeeding alternatives, RTD infant milk products fall short when compared with breast milk in terms of nutritional and immune strengthening benefits. Ingredients such as DHA, lutein, and vitamin E, which are found in breast milk, are frequently used ingredients for breastfeeding alternatives. These ingredients used for preparing RTD infant milk formula are low in concentration, on comparison to the composition found in breast milk.

Market Dynamics

Market Drivers

  • Breastfeeding alternatives for specified maternal conditions, convenience, and flexibility
  • Product innovation
  • Wide product portfolio

Market Challenges

  • Gap between nutritional and immune strengthening benefits from breast milk
  • Sterility issues of breastfeeding alternatives causing adverse health effects

Market Trends

  • Packaging innovation
  • Increase in demand for organic and non-GMO infant formulas

Key vendors

  • Abbott Laboratories (Abbott)
  • Danone
  • Mead Johnson Nutrition
  • Nestlé

Other prominent vendors

  • Arla Foods
  • Amara Baby Food
  • Baby Gourmet
  • Ella's Kitchen Group
  • Friso
  • GreenMonkey (GreenZoo)
  • Hero Group
  • Morinaga
  • Meiji
  • Nurture (Happy Family)
  • One Earth Farms
  • Parent's Choice
  • Plum Organics
  • Stonyfield Farm

For more information about this report visit http://www.researchandmarkets.com/research/qk4r2c/global_rtd_infant


Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716



© 2017 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.